Giacomo De Luca

Dr. Giacomo De Luca is a rheumatologist at the Unit of Immunology, Rheumatology, Allergology, and Rare Diseases at IRCCS Ospedale San Raffaele, directed by Professor Lorenzo Dagna.

Dr. De Luca completed his degree in Medicine and Surgery in 2009 with honors at the Università Cattolica del Sacro Cuore in Rome, and he achieved his specialization in Rheumatology at the same university in 2015 with honors. He then conducted translational research as a Fellow in Rheumatology at the Institute of Infection, Immunity and Inflammation, University of Glasgow (UK), from June to November 2015, as part of a research project funded by the Italian Society of Rheumatology.

From 2016 to 2019, he worked as a Research Fellow at Università Vita-Salute San Raffaele on three research projects focused on systemic sclerosis.

Since September 2021, he has held the position of Fixed-Term Researcher, Type A, in the scientific sector MED/50 Applied Medical Technical Sciences. He is currently a University Researcher at Università Vita-Salute San Raffaele and a Lecturer in Medical Semiotics (of which he is the coordinator), Medical Therapy, and Semiotics in the Faculty of Medicine in both the Italian and MD International courses, as well as Semiotics and Pathophysiology, Internal Medicine, and Emergency Medicine in the Nursing Degree Program.

Dr. De Luca is the Coordinator of the Scleroderma Unit of UnIRAR, a multidisciplinary clinic dedicated to the diagnosis, treatment, and monitoring of systemic sclerosis.

He is also the regional contact for IRCCS Ospedale San Raffaele for Systemic Sclerosis and the contact person for the center for the treatment of autoimmune myocarditis (and a member of the Myocarditis Disease Unit), systemic connective tissue diseases, inflammatory myopathies, Behçet's disease, sarcoidosis, Buerger's disease (thromboangiitis obliterans), recurrent idiopathic pericarditis, and pyoderma gangrenosum.

Additionally, Dr. De Luca manages chronic arthritis (rheumatoid arthritis, psoriatic arthritis, spondyloarthritis), fibromyalgia and chronic pain syndrome, systemic vasculitis, microcrystalline arthritis, extra-articular rheumatism, and autoinflammatory diseases.

He is recognized for his fruitful research activities aimed at better understanding the pathogenic mechanisms of systemic sclerosis and inflammatory cardiomyopathies, and identifying innovative therapeutic strategies for these conditions. His intensive research has led to significant scientific recognitions and funding both nationally and internationally.

Dr. De Luca is the author of over 115 scientific papers published in international journals and has authored over 60 abstracts presented at national and international congresses.

He is a member of important national (SPRING) and international (EUSTAR, ERN-ReConnect, EUSTAR YIG) research groups focused on clinical and translational research on systemic sclerosis and other rare diseases, and a member of the Italian Society of Rheumatology and the ESC (European Society of Cardiology) working group on Myocardial & Pericardial Diseases.